Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: An Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy

International Journal of Cardiology

Volumn 172, Issue 2, 2014, Pages 356-363

  Damman, Peter ^a   Kempf, Tibor ^b   Windhausen, Fons ^a   Van Straalen, Jan P ^a   Guba Quint, Anja ^b   Fischer, Johan ^a   Tijssen, Jan G P ^a   Wollert, Kai C ^b   De Winter, Robbert J ^a   Hirsch, Alexander ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Growth differentiation factor 15; Long term outcomes; Non ST elevation acute coronary syndrome

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; TROPONIN; BIOLOGICAL MARKER; TROPONIN T;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTEGRATED DISCRIMINATION IMPROVEMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NET RECLASSIFICATION IMPROVEMENT; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; ACUTE CORONARY SYNDROME; BLOOD; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 84900279381     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.01.025     Document Type: Article

References (22)

1. B.M. Scirica Acute coronary syndrome: emerging tools for diagnosis and risk assessment J Am Coll Cardiol 55 2010 1403 1415
2. T. Kempf, M. Eden, and J. Strelau et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury Circ Res 98 2006 351 360
3. T. Kempf, A. Zarbock, and C. Widera et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice Nat Med 17 2011 581 588
4. J. Xu, T.R. Kimball, and J.N. Lorenz et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation Circ Res 98 2006 342 350
5. D. Schlittenhardt, A. Schober, and J. Strelau et al. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions Cell Tissue Res 318 2004 325 333
6. K.C. Wollert, T. Kempf, and T. Peter et al. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome Circulation 115 2007 962 971
7. K.C. Wollert, T. Kempf, and B. Lagerqvist et al. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome Circulation 116 2007 1540 1548
8. R.J. de Winter, F. Windhausen, and J.H. Cornel et al. Early invasive versus selectively invasive management for acute coronary syndromes N Engl J Med 353 2005 1095 1104
9. A. Hirsch, F. Windhausen, J.G. Tijssen, F.W. Verheugt, J.H. Cornel, and R.J. de Winter Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study Lancet 369 2007 827 835
10. P. Damman, A. Hirsch, F. Windhausen, J.G. Tijssen, and R.J. de Winter 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome J Am Coll Cardiol 55 2010 858 864
11. T. Kempf, R. Horn-Wichmann, and G. Brabant et al. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay Clin Chem 53 2007 284 291
12. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
13. F. Windhausen, A. Hirsch, and G.T. Sanders et al. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy Am Heart J 153 2007 485 492
14. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
15. P. Damman, M.A. Beijk, and W.J. Kuijt et al. Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction J Am Coll Cardiol 57 2011 29 36
16. M.J. Pencina, R.B. D'Agostino Sr., and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
17. M.P. Bonaca, D.A. Morrow, and E. Braunwald et al. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22 Arterioscler Thromb Vasc Biol 31 2011 203 210
18. L. Lind, L. Wallentin, and T. Kempf et al. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study Eur Heart J 30 2009 2346 2353
19. K.M. Eggers, T. Kempf, and L. Lind et al. Relations of growth-differentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects Scand J Clin Lab Invest 72 2012 45 51
20. K.M. Eggers, T. Kempf, and B. Lagerqvist et al. Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome Circ Cardiovasc Genet 3 2010 88 96
21. A. Hirsch, F. Windhausen, and J.G. Tijssen et al. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias Eur Heart J 30 2009 645 654
22. P. Damman, L. Wallentin, and K.A. Fox et al. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR) Circulation 125 2012 568 576